Recent Updates
Recently added Catalysts
PHG

ANNUAL REPORT exv99w1 Table of Contents A new approach to annual reporting Philips is striving to combine timely reporting of its annual financial results with full disclosure and transparency. This year, Philips has aga

Key Takeaway: Table of Contents A new approach to annual reporting Philips is striving to combine timely reporting of its annual financial results with full disclosure and transparency. This year, Philips has again accelerated the reporting of its annual financial results. The performance

Full Press Release Details

Table of Contents

A new approach to annual reporting
Philips is striving to combine timely reporting of its annual financial results with full
disclosure and transparency.
This year, Philips has again accelerated the reporting of its annual financial results. The
performance in 2004 has been summarized in a separate booklet entitled Annual Review 2004 of
Koninklijke Philips Electronics N.V. ( Royal Philips Electronics , or the Company ), which was
published on January 27, 2005.
Full financial information and further statutory and other information, including the Operating and
financial review and prospects, is contained in this Annual Report.
Forward-looking statements
This document contains certain forward-looking statements with respect to the financial condition,
results of operations and business of Philips and certain of the plans and objectives of Philips
with respect to these items (including, but not limited to, cost savings), in particular the
outlook paragraph of the Operating and financial review and prospects in this Annual Report
By their nature, forward-looking statements involve risk and uncertainty because they relate to
events and depend on circumstances that will occur in the future. There are a number of factors
that could cause actual results and developments to differ materially from those expressed or
implied by these forward-looking statements. These factors include, but are not limited to, levels
of consumer and business spending in major economies, changes in consumer tastes and preferences,
changes in law, the performance of the financial markets, pension costs, the levels of marketing
and promotional expenditures by Philips and its competitors, raw materials and employee costs,
changes in exchange and interest rates (in particular changes in the euro and the US dollar can
materially affect results), changes in tax rates and future business combinations, acquisitions or
dispositions and the rate of technological changes, political and military developments in
countries where Philips operates, the risk of a downturn in the semiconductor market, Philips
ability to secure short-term profitability and invest in long-term growth in Lighting and product
R D in Medical Systems, and industry consolidation.
Statements regarding market share, including as to Philips competitive position, contained in this
document are based on outside sources such as specialized research institutes, industry and dealer
panels in combination with management estimates. Where full-year information regarding 2004 is not
yet available to Philips, those statements may also be based on estimates and projections prepared
by outside sources or management. Rankings are based on sales unless otherwise stated.
Use of non-GAAP information
In presenting and discussing the Philips Group s financial position, operating results and cash
flows, management uses certain non-GAAP financial measures. These non-GAAP financial measures
should not be viewed in isolation as alternatives to the equivalent GAAP measure(s) and should be
used in conjunction with the most directly comparable US GAAP measure(s). A discussion of the
non-GAAP measures included in this document and a reconciliation of such measures to the most
directly comparable US GAAP measure(s) are contained on pages 210 and 211 in this document.
Philips Annual Report 2004 1
4 Financial highlights
7 Message from the President
12 Governance
14 Reporting and Control
17 Board of Management
18 Group Management Committee
20 Supervisory Board
21 Supervisory Board Report
Information on the Philips Group
28 The structure of the Philips Group
28 Business overview
29 Product sectors and principal products
39 Property, plant and equipment
40 Cooperative business activities and unconsolidated companies
Operating and financial review and prospects
43 Introduction
44 Group performance 2004 compared to 2003
44 Management summary
45 Performance of the Group
50 Performance by sector
58 Performance by region
59 Employment
60 Group performance 2003 compared to 2002
67 Restructuring and impairment charges
70 Liquidity and capital resources
76 Risk management
82 Critical accounting policies
85 IFRS information
86 Other information
86 Proposed dividend to shareholders
86 Share repurchase program
86 MedQuist
87 Outlook
89 Report of independent registered public accounting firm
Financial statements of the Philips Group
90 Consolidated statements of income
92 Consolidated balance sheets
94 Consolidated statements of cash flows
96 Consolidated statements of stockholders equity
97 Accounting policies
105 New accounting standards
106 Notes to the consolidated financial statements
Dutch GAAP information
176 Accounting principles
176 Reconciliation US to Dutch GAAP
178 Philips Group
178 Consolidated statements of income
180 Consolidated balance sheets
182 Consolidated statements of stockholders equity
183 Notes to the consolidated financial statements
187 Royal Philips Electronics
187 Balance sheets and statements of income
188 Notes to the financial statements
Other information
193 Auditors report
194 Proposed dividend to shareholders
195 Corporate governance
210 Reconciliation of non-GAAP information
212 The Philips Group in the last eleven years
214 Shareholder information
2 Philips Annual Report 2004

Table of Contents

Financial statements of the Philips Group
Notes to the consolidated financial statements of the Philips Group
106 (1 ) Acquisitions and divestments
112 (2 ) Income from operations
120 (3 ) Financial income and expenses
120 (4 ) Income taxes
124 (5 ) Investments in unconsolidated companies
129 (6 ) Minority interests
129 (7 ) Cumulative effect of a change in accounting principles
130 (8 ) Earnings per share
130 (9 ) Receivables
131 (10 ) Inventories
131 (11 ) Other current assets
132 (12 ) Other non-current financial assets
133 (13 ) Non-current receivables
133 (14 ) Other non-current assets
134 (15 ) Property, plant and equipment
135 (16 ) Intangible assets excluding goodwill
136 (17 ) Goodwill
137 (18 ) Accrued liabilities
137 (19 ) Provisions
139 (20 ) Pensions
144 (21 ) Postretirement benefits other than pensions
146 (22 ) Other current liabilities
146 (23 ) Short-term debt
147 (24 ) Long-term debt
149 (25 ) Other non-current liabilities
149 (26 ) Commitments and contingent liabilities
153 (27 ) Stockholders equity
154 (28 ) Cash from derivatives
154 (29 ) Proceeds from other non-current financial assets
154 (30 ) Assets received in lieu of cash from the sale of businesses
155 (31 ) Related-party transactions
155 (32 ) Share-based compensation
160 (33 ) Information on remuneration of the individual members of the Board of Management and the Supervisory Board
165 (34 ) Financial instruments, derivatives and risks
171 (35 ) Information relating to product sectors and main countries
Dutch GAAP information
Notes to the consolidated financial statements of the Philips Group
183 (36 ) Income from operations
183 (37 ) Financial income and expenses
183 (38 ) Income taxes
184 (39 ) Unconsolidated companies
185 (40 ) Other non-current assets
186 (41 ) Goodwill consolidated companies
186 (42 ) Stockholders equity
Notes to the financial statements of Royal Philips Electronics
188 (A ) Receivables
188 (B ) Investments in affiliated companies
189 (C ) Other non-current financial assets
189 (D ) Tangible fixed assets
189 (E ) Intangible fixed assets
190 (F ) Other liabilities
190 (G ) Short-term debt
190 (H ) Provisions
190 (I ) Long-term debt
191 (J ) Stockholders equity
192 (K ) Net income
192 (L ) Employees
192 (M ) Obligations not appearing in the balance sheet
Philips Annual Report 2004 3

Table of Contents

Financial highlights
4 Philips Annual Report 2004

Table of Contents

all amounts in millions of euros unless otherwise stated
2002 2003 2004
Sales 31,820 29,037 30,319
Income from operations 420 488 1,607
As a % of sales 1.3 1.7 5.3
Results relating to unconsolidated companies (1,346 ) 506 1,422
Net income (loss) (3,206 ) 695 2,836
Per common share in euros - basic (2.51 ) 0.54 2.22
- diluted (2.51 ) 0.54 2.21
Dividend paid per common share in euros 0.36 0.36 0.36
Net operating capital 10,539 8,071 7,192
Cash flows before financing activities 1,980 2,734 3,350
Stockholders equity 13,919 12,763 14,860
Per common share in euros 10.91 9.97 11.60
Net debt : group equity ratio 27:73 18:82 1:99
Employees at December 31 170,087 164,438 161,586
Philips Annual Report 2004 5

Table of Contents

6 Philips Annual Report 2004

Table of Contents

Message from the President
With the introduction of our new brand promise Sense and simplicity we are creating a unique,
differentiated positioning that will further enhance our value proposition to our customers.
2004 was a year of major progress for Philips. Driven by our focus on operational performance and
cost management, our financial results showed considerable improvement, delivering a return well in
excess of our cost of capital. With the consistent execution of our management agenda for 2004 we
also took an important step forward in implementing our strategy to transform Philips into a truly
market-driven healthcare, lifestyle and technology company. And with the introduction of our new
brand promise Sense and simplicity we are creating a unique, differentiated positioning that will
further enhance our value proposition to our customers.
Strong financial performance
Adjusted for the weakening US dollar, sales were up almost 9% compared to 2003, mainly in
Semiconductors, driven by a rebound in the industry, and in Consumer Electronics. Going forward,
however, our focus on innovation is providing Philips with a basis for stronger growth across all
our divisions. Capitalizing on the significant cost savings and the process improvements we have
made over the past few years, income from operations increased to EUR 1,607 million, or 5.3% of
sales, moving us closer to our goal of a 7-10 % operating margin, to be realized within one to two
years from now. Income from operations includes a gain from the initial public offering of NAVTEQ
(EUR 635 million) as well as an impairment charge for MedQuist (EUR 590 million) and the net cost
of settlement of litigation with Volumetrics (EUR 133 million).
Philips Annual Report 2004 7

Table of Contents

Message from the President
Results from unconsolidated companies rose to EUR 1,422 million, driven by improved performance by
TSMC and our LCD venture LG.Philips LCD. Thanks to its successful IPO, the latter company now has
direct access to the capital markets. We also took steps to dispose of some more of our financial
holdings. Altogether, this resulted in Group net income of EUR 2,836 million, or EUR 2.22 per
share. Cash flow from operating activities was strong at EUR 2,697 million. On a net basis, the
Company is now virtually debt-free, which will allow us to pursue our growth plans while also
returning cash to you in the form of a higher dividend.
Fulfilling our commitments
In my message to you last year, we committed to the following management agenda for 2004:
To achieve 14% EBITA at Medical Systems in 2004
To implement CE s renewal program to achieve 4 4.5% operating margin by the end of 2005
To accelerate profitable growth through the sustained transformation of Philips into a market-driven organization
To increase the number of product leadership positions and the rate of innovation across the Group
To continue to focus on reducing indirect costs to achieve additional savings of EUR 250 million.
I would now like to review these commitments and discuss how we performed.
14% EBITA at Medical Systems
I am very proud to report that we met our target of 14% EBITA. Actually we surpassed it, achieving
14.4% excluding the Volumetrics settlement. The management team at Medical Systems has successfully
Last updated: Feb 23, 2005